Inhibrx, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Inhibrx, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q1 2024.
  • Inhibrx, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 54.6M shares, a 25.2% increase year-over-year.
  • Inhibrx, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 47.1M shares, a 17.5% increase from 2022.
  • Inhibrx, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 40.1M shares, a 5.52% increase from 2021.
  • Inhibrx, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 38M shares, a 50.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 54.6M +11M +25.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 47.1M +7.02M +17.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 47.2M +8.08M +20.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 43.6M +4.6M +11.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 43.6M +4.56M +11.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 40.1M +2.1M +5.52% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 39.1M +1.18M +3.11% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 39M +1.22M +3.22% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 39M +1.28M +3.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 38M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 37.9M +11.1M +41.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 37.8M +19.7M +108% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 37.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 26.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 18.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.